慢性炎症性皮肤病的现状：我们所处的位置以及前进的方向

Current Landscape of Chronic Inflammatory Dermatoses: Where We Are and Where We Are Heading.

作者信息

Sójka Aleksandra, Krajewski Piotr K

机构信息

University Centre of General Dermatology and Oncodermatology, Wroclaw Medical University, 50-556 Wrocław, Poland.

出版信息

Curr Issues Mol Biol. 2024 Sep 16;46(9):10259-10263. doi: 10.3390/cimb46090611.

DOI:10.3390/cimb46090611

PMID:39329963

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11430369/

Abstract

Chronic inflammatory dermatoses represent a heterogeneous group of skin disorders that are often characterized by persistent and relapsing inflammation, with complex underlying pathomechanisms [...].

摘要

慢性炎症性皮肤病是一组异质性的皮肤疾病，其特征通常为持续性和复发性炎症，伴有复杂的潜在发病机制[...]。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd0e/11430369/25899e09a9c9/cimb-46-00611-g001.jpg

相似文献

Current Landscape of Chronic Inflammatory Dermatoses: Where We Are and Where We Are Heading.

Curr Issues Mol Biol. 2024 Sep 16;46(9):10259-10263. doi: 10.3390/cimb46090611.

Pregnancy and skin.

J Family Med Prim Care. 2014 Oct-Dec;3(4):318-24. doi: 10.4103/2249-4863.148099.

[Neutrophilic dermatosis and neutrophil disorders. A study of 31 clinical cases].

Bull Acad Natl Med. 2005 May;189(5):917-31; discussion 931-3.

[Neutrophilic dermatoses].

Rev Med Interne. 2005 Jan;26(1):41-53. doi: 10.1016/j.revmed.2004.06.015.

Novel Therapeutic Approaches and Targets for the Treatment of Neutrophilic Dermatoses, Management of Patients with Neutrophilic Dermatoses and Future Directions in the Era of Biologic Treatment.

Curr Pharm Biotechnol. 2021;22(1):46-58. doi: 10.2174/1389201021666200503050803.

Prevalence, number and morphological types of multinucleated histiocytic giant cells in equine inflammatory dermatoses: a retrospective light microscopic study of skin-biopsy specimens from 362 horses.

Equine Vet J. 2009 Apr;41(4):406-9. doi: 10.2746/042516409x374212.

Biologics for Allergic Dermatologic Diseases.

Curr Allergy Asthma Rep. 2020 Jun 6;20(8):35. doi: 10.1007/s11882-020-00923-7.

Drug management of neutrophilic dermatoses.

Expert Rev Clin Pharmacol. 2017 Oct;10(10):1119-1128. doi: 10.1080/17512433.2017.1356719. Epub 2017 Jul 27.

[Paraneoplastic dermatoses].

Ther Umsch. 1995 Apr;52(4):282-7.

Neutrophilic dermatoses: a broad spectrum of disease.

G Ital Dermatol Venereol. 2018 Apr;153(2):265-272. doi: 10.23736/S0392-0488.18.05841-8. Epub 2018 Jan 24.

本文引用的文献

Biologics for Psoriasis.

Dermatol Clin. 2024 Jul;42(3):339-355. doi: 10.1016/j.det.2024.02.001. Epub 2024 Mar 13.

Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials.

Lancet. 2024 Jun 8;403(10443):2504-2519. doi: 10.1016/S0140-6736(24)00101-6. Epub 2024 May 22.

Targeted Systemic Therapies for Adults with Atopic Dermatitis: Selecting from Biologics and JAK Inhibitors.

Am J Clin Dermatol. 2024 Mar;25(2):179-193. doi: 10.1007/s40257-023-00837-w. Epub 2024 Jan 12.

The new era of JAK inhibitors: Impelling updates in Alopecia Areata Guideline.

J Eur Acad Dermatol Venereol. 2024 Jul;38(7):e602-e606. doi: 10.1111/jdv.19765. Epub 2023 Dec 22.

JAK-STAT pathway inhibitors in dermatology.

An Bras Dermatol. 2023 Sep-Oct;98(5):656-677. doi: 10.1016/j.abd.2023.03.001. Epub 2023 May 23.

Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials.

Lancet. 2023 Mar 4;401(10378):747-761. doi: 10.1016/S0140-6736(23)00022-3. Epub 2023 Feb 3.

Busting the myth of methotrexate chronic hepatotoxicity.

Nat Rev Rheumatol. 2023 Feb;19(2):96-110. doi: 10.1038/s41584-022-00883-4. Epub 2022 Dec 23.

Treatment With Dupilumab in Patients With Atopic Dermatitis: Systematic Review and Meta-Analysis.

J Cutan Med Surg. 2022 Nov-Dec;26(6):613-621. doi: 10.1177/12034754221130969. Epub 2022 Oct 9.

TNF-α inhibitors biosimilars as first line systemic treatment for moderate-to-severe chronic plaque psoriasis.

Expert Rev Clin Immunol. 2020 Jun;16(6):591-598. doi: 10.1080/1744666X.2020.1771182. Epub 2020 Jun 4.

Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis: A Phase 3 Randomized Clinical Trial.

JAMA Dermatol. 2020 Jan 1;156(1):44-56. doi: 10.1001/jamadermatol.2019.3336.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

慢性炎症性皮肤病的现状：我们所处的位置以及前进的方向

Current Landscape of Chronic Inflammatory Dermatoses: Where We Are and Where We Are Heading.

作者信息

机构信息

出版信息

相似文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

慢性炎症性皮肤病的现状：我们所处的位置以及前进的方向

Current Landscape of Chronic Inflammatory Dermatoses: Where We Are and Where We Are Heading.

作者信息

机构信息

出版信息

相似文献

本文引用的文献